Table 1.

Overview on additive and synergistic effects with existing antibiotics indicated by FICI values and combined MIC values, respectively.

No.	MRSA strain	Amikacin	Ampicillin	Azithromycin	Ceftazidime	Ciprofloxacin	Gentamicin	Levofloxacin	Norfloxacin	Oxacillin	Additional antibiotics	References
4	MRSA-011		0.5									Zeng et al. (2022)
	MRSA-003		0.375
5	MRSA-011		0.5									Zeng et al. (2022)
	MRSA-003		0.5
7	ATCC 33591										Ethidium bromide: 7.8 μg/mL (2×)	Zuo et al. (2011)
9	OMS 7		0.625							0.5		Yu et al. (2005)
	MRSA 004			0.375				0.5				Zuo et al. (2012)
	MRSA 055			0.25				0.375
	MRSA 123			0.25				0.375
	MRSA 144			0.375				0.5
	MRSA 189			0.375				0.5
	MRSA 240			0.625				0.75
	MRSA 276			0.375				0.5
	MRSA 294			0.5				0.375
	MRSA 328			0.25				0.375
	MRSA 330			0.188				0.5
10	MRSA 004			0.281				0.375				Zuo et al. (2012)
	MRSA 055			0.156				0.25
	MRSA 123			0.375				0.188
	MRSA 144			0.375				0.5
	MRSA 189			0.5				0.188
	MRSA 240			0.5				0.5
	MRSA 276			0.375				0.5
	MRSA 294			0.281				0.5
	MRSA 328			0.5				0.375
	MRSA 330			0.313				0.5
11	SA1199B								0.375			Yu et al. (2019)
46	ATCC 43300									0.25 μg/mL (256×)/0.125	Meropenem: 0.094	Dettweiler et al. (2020)
											Vancomycin: 0.625
53	XU212										Tetracycline: 64 μg/mL (2×)	Oluwatuyi et al. (2004)
	RN4220										Erythromycin: 32 μg/mL (8×)
	SA1199B								32 μg/mL (1×)		Ethidium bromide: 8 μg/mL (2×)
54	XU212										Tetracycline: 32 μg/mL (4×)	Oluwatuyi et al. (2004)
	RN4220										Erythromycin: 256 μg/mL (1×)
	SA1199B								32 μg/mL (1×)
84	MRSA	0.313–1			0.5–1		0.75–1.5				Cefazolin: 0.625–2	Zuo et al. (2015)
85	MRSA	0.078–1					0.313–1				Amoxicillin: 0.625–2	Zuo et al. (2015)
90	T28.1					0.49–1	0.14–1			0.28–0.75	Rifampicin: 0.25–0.75	Bocquet et al. (2019)
91	T28.1					0.38–1.5	0.03–0.28			0.5–0.76	Rifampicin: 1–5	Bocquet et al. (2019)
94	MRSA	0.25–2					0.25–1				Etimicin: 0.375–0.75	Zuo et al. (2014)
											Strepomycin: 0.25–1
95	MRSA			0.47–0.75	0.188–2		0.375–1				Penicillin: 0.625–1	Zuo et al. (2014)
96	MRSA	0.625–1			0.5–1		0.75–1.5				Cefazolin: 0.75–2	Zuo et al. (2014)
108	MRA 004		0.5	1.5	0.25			0.312				An et al. (2011)
	MRA 055		0.625	1	0.25			0.312
	MRA 092		0.5	1	0.187			0.5
	MRA 123		0.5	1	0.25			0.25
	MRA 144		2	1	0.375			0.5
	MRA 155		1	1.5	0.25			0.375
	MRA 189		1	1.5	0.187			0.5
	MRA 247		0.75	1.5	0.375			0.375
	MRA 328		2	1	0.25			0.375
	MRA 330		0.625	1.5	0.375			0.312
116	ATCC 43300					0.16	0.13			0.14	Tetracycline: 0.14	Aelenei et al. (2020)
122	MRSA 1903									0.625		Navrátilová et al. (2016)
	MRSA 3202									0.375
	MRSA 62097									1.008
	MRSA 67755									0.508
	MRSA 1679									0.266
123	MRSA 1903									0.266		Navrátilová et al. (2016)
	MRSA 63718									1.031
	MRSA 3202									0.5
	MRSA 62097									0.563
	MRSA 67755									1.008
	MRSA 1679									0.625
127	ATCC 43300					0.38	0.19			0.27	Tetracycline: 0.38	Aelenei et al. (2020)
128	ATCC 29213						0.135					Meenu et al. (2021)
140	ATCC 1708										Meropenem: 0.375	Kumarihamy et al. (2022)
											Vancomycin: 1
187	ATCC 33591		0.5							0.5		Lee et al. (2010)
	DPS-1		0.5							0.5
	DPS-2		0.5							0.5
	DPS-3		0.5							0.5
	DPS-4		0.37							0.5
	DPS-5		0.5							0.5
	DPS-6		0.5							0.75
	DPS-7		0.5							0.5
	DPS-8		0.5							0.5
	DPS-9		0.37							0.5
	DPS-10		0.5							0.5
	DPS-11		0.37							0.5
	DPS-12		0.37							0.5
	DPS-13		0.37							0.5
	DPS-14		0.5							0.37
	DPS-15		0.37							0.5
190	T28.1					0.63–1	9			0.19–1.25	Rifampicin: 2.2–6	Bocquet et al. (2019)